Press
Press
2024-09-26 15:35
Acarix announces outcome of warrant exercise of series 3
Acarix AB ("Acarix" or the "Company") today announces the outcome of the exercise of warrants of series 3 issued in connection with the Company’s rights...
2024-09-12 14:02
Board member purchases shares in Acarix
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces that Dr. Tony Daz, Board member of Acarix, purchased 2,000,600 shares in the...
2024-09-11 08:00
Acarix informs of exercise price for the warrants of series TO 3
Acarix AB ("Acarix" or the "Company"), a leader in rapid AI and acoustics-based cardiac diagnostics, announces that the exercise price of warrants of series...
2024-09-02 10:35
Nationally Recognized Cardiology Practice Places Multiunit Order of the Acarix CADScor System
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce that Connected Cardiovascular Care Associates (C3), the first...
2024-09-02 09:45
CEO purchases shares in Acarix
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces that Aamir Mahmood, President and CEO of Acarix, purchased 2,261,753 shares...
2024-09-01 10:33
FILTER-SCAD Study Results Demonstrate Need for Point of Care Rule-Out Options for Coronary Artery Disease in Low-Risk Patients
Malmö, Sweden — Acarix, a leader in advanced acoustic-based cardiac diagnostics, announced that the results of the FILTER-SCAD trial released today...
2024-08-28 18:47
Acarix receives additional declaration of intent and fully secures the warrants of series TO 3 through guarantee agreements
Acarix AB ("Acarix" or the "Company"), a leader in rapid AI and acoustics-based cardiac diagnostics, announces that the Company has received additional...
2024-08-26 10:14
Acarix Secures Order with National Concierge Healthcare Organization
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces its first order of the CADScor System with a prominent U.S. concierge healthcare...
Acarix AB ("Acarix" or the "Company") has received declarations of intent to exercise Warrants of series TO 3 (the "Warrants") from a number of major holders...
2024-08-22 21:42
Acarix Q2 2024 video presentation
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, held a live presentation of the second-quarter results today Thursday, August 22...
2024-08-22 08:00
Acarix AB (publ) publishes Interim Report, April – June 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 2024. The company...
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, will publish its second-quarter results on Thursday, August 22, 2024, at 08.00 am...
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces updates on the ongoing reimbursement application process and dialogue with...
2024-08-12 11:16
Acarix expands within US wellness exam market
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces expanded use of the CADScor System within wellness exams as part of self-insured...
2024-07-15 14:00
Acarix shares begin trading on the US-based OTCQB Market
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce that the Acarix shares (OTCQB: ACIXF) begin trading today...
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce a significant reorder of single-use patches by a busy primary...
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce an additional multi order of the CADScor System to be utilized...
2024-07-03 23:11
ACARIX CARRIES OUT A DIRECTED SHARE ISSUE OF SEK 21 MILLION
THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG...
2024-07-03 23:11
ACARIX GENOMFÖR EN RIKTAD EMISSION OM 21 MSEK
DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, DISTRIBUERAS ELLER PUBLICERAS, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, BELARUS...
2024-06-26 09:54
Acarix Secures Multi-Unit Order from In-Home Concierge Practice
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, has announced the CADScor System is now being utilized as a diagnostic aid for symptomatic...
2024-06-11 13:14
Acarix announces enrollment of first patient in US-based Clinical Workflow Evaluation Study
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce the enrollment of the first patient in its first US-based...
2024-05-27 10:20
Acarix welcomes Jeff Thomas as new Head of US Sales
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces the appointment of Jeff Thomas as the new Head of US Sales, effective June...
2024-05-20 10:40
Acarix CPT III Code Removed from United Healthcare Medicare Advantage Noncovered List
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces effective May 1, 2024, that the CADScor System CPT III 0716T code has been...
2024-05-14 14:15
Announcement from the annual general meeting in Acarix AB
The annual general meeting 2024 (the "AGM") of Acarix AB ("Acarix" or the "Company") was held today on 14 May 2024 and the following resolutions were passed...
2024-05-14 14:15
Kommuniké från årsstämma i Acarix AB
Årsstämman 2024 i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 14 maj 2024 varvid aktieägarna fattade följande beslut.
2024-05-14 08:00
Acarix AB (publ) publishes Interim Report, January – March 2024
Setting the stage for a strong 2024 and beyond
2024-05-13 09:45
Acarix secures a multi-unit order from major cardiology practice with several offices in Florida
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, has announced that the CADScor System is now available at multiple clinics within...
2024-05-10 09:30
Invitation to presentation of Acarix´s first quarter report
Acarix will publish its first quarter results on Tuesday 14 May 2024 at 08.00 am (CEST). A live webcast will be held at 15.00 (CEST) the same day, where...
2024-05-06 10:12
CADScor System is now being utilized by Leading Cardiology Practice in the New York Capital Region
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the integration of the CADScor System at Capital Cardiology Associates' newest...
2024-05-03 16:00
Proposal by the nomination committee prior to the 2024 annual general meeting of Acarix AB (publ)
The Nomination Committee of Acarix consists of Jan Poulsen (Chairman) representing Life Science Invest Fund 1 among others, Anton Rehnström representing...
About Acarix
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based Coronary Artery Disease (CAD) rule-out.
The CE-mark approved and FDA De Novo cleared Acarix CADScor®System is for patients experiencing stable chest pain with suspected CAD and is designed to help reduce millions of unnecessary and costly diagnostic procedures.2 CADScor®System calculates a patient-specific CAD-score non-invasively in 10 minutes with at least 96% confidence (Negative Predictive Value).¹
Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX).
- User manual US-FDA v.12.Y, prevalence 10,7%
- Shaw LJ, Marwick TH, Zoghbi WA, Hundley WG, Kramer CM, Achenbach S, Dilsizian V, Kern MJ, Chandrashekhar Y, Narula J. Why all the focus on cardiac imaging? JACC Cardiovasc Imaging. 2010 Jul;3(7):789-94. doi: 10.1016/j.jcmg.2010.05.004. PMID: 20633864.